Loomis, Sayles & Company’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.1M Sell
49,039
-43,116
-47% -$12.4M 0.02% 297
2025
Q1
$28.4M Buy
92,155
+13,720
+17% +$4.23M 0.04% 183
2024
Q4
$27.7M Sell
78,435
-70,046
-47% -$24.7M 0.03% 212
2024
Q3
$53.2M Sell
148,481
-83,408
-36% -$29.9M 0.07% 125
2024
Q2
$73.9M Sell
231,889
-20,135
-8% -$6.41M 0.1% 80
2024
Q1
$57.9M Sell
252,024
-2,020
-0.8% -$464K 0.08% 104
2023
Q4
$55.9M Sell
254,044
-11,255
-4% -$2.47M 0.09% 109
2023
Q3
$59.9M Sell
265,299
-4,984
-2% -$1.13M 0.1% 95
2023
Q2
$59.7M Buy
270,283
+11,044
+4% +$2.44M 0.1% 103
2023
Q1
$58.1M Buy
259,239
+56,781
+28% +$12.7M 0.1% 104
2022
Q4
$56.3M Sell
202,458
-1,007
-0.5% -$280K 0.11% 97
2022
Q3
$42.6M Buy
203,465
+37,643
+23% +$7.88M 0.09% 117
2022
Q2
$39.1M Buy
165,822
+96,169
+138% +$22.7M 0.07% 131
2022
Q1
$12.5M Sell
69,653
-4,074
-6% -$731K 0.02% 347
2021
Q4
$15.9M Buy
73,727
+210
+0.3% +$45.4K 0.02% 337
2021
Q3
$13.6M Sell
73,517
-2,229
-3% -$411K 0.02% 347
2021
Q2
$13.6M Sell
75,746
-327
-0.4% -$58.7K 0.02% 351
2021
Q1
$12.7M Sell
76,073
-5,694
-7% -$952K 0.02% 356
2020
Q4
$12.4M Sell
81,767
-26,964
-25% -$4.09M 0.02% 324
2020
Q3
$11M Sell
108,731
-2,485
-2% -$251K 0.02% 307
2020
Q2
$13.5M Sell
111,216
-1,664
-1% -$201K 0.02% 271
2020
Q1
$10.7M Buy
112,880
+14,294
+14% +$1.36M 0.02% 272
2019
Q4
$8.68M Sell
98,586
-778
-0.8% -$68.5K 0.01% 375
2019
Q3
$7.92M Buy
99,364
+24,354
+32% +$1.94M 0.02% 376
2019
Q2
$5.86M Buy
+75,010
New +$5.86M 0.01% 398
2018
Q1
Sell
-86
Closed -$13K 920
2017
Q4
$13K Sell
86
-52
-38% -$7.86K ﹤0.01% 769
2017
Q3
$16K Sell
138
-58
-30% -$6.73K ﹤0.01% 765
2017
Q2
$25K Buy
+196
New +$25K ﹤0.01% 732
2016
Q2
Sell
-77
Closed -$9K 1125
2016
Q1
$9K Sell
77
-69
-47% -$8.07K ﹤0.01% 847
2015
Q4
$23K Hold
146
﹤0.01% 781
2015
Q3
$19K Buy
+146
New +$19K ﹤0.01% 858